COVID-19. U07.1
Conditions
Interventions
Intervention 1: Control group: Positive PCR patients referred to Bushehr Persian Gulf Hospital who received placebo. Intervention 2: Intervention group: PCR positive patients referred to Bushehr Persi
Sponsors
NICOVIDEO Research Company
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Participants age are within 18-70 years Participants should not be pregnant or Breastfeeding Participants who not ventilator dependence
Exclusion criteria
Exclusion criteria: History of allergy to Organosulfur Compounds History of allergies to garlic and onions The patient has a history of hypotension The patient has a history of Gastrointestinal bleeding hypotension at the beginning of the study (below 120/80) The patient has a history immunodeficiency diseases The inability of the patient to swallow the oral medication or via NG tube
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcomes including clinical signs, lymphocyte percentage, LDH, SpO2, CRP, CBC. Timepoint: At baseline then 10 days from initiated time. Method of measurement: Information of hospitalized patients through direct examination and information entered in the file and patients who are discharged are referred to the clinic on an outpatient basis on the tenth day. | — |
Secondary
| Measure | Time frame |
|---|---|
| Lymphocytopenia. Timepoint: Before starting the study, 10 days later. Method of measurement: Cell Counter (CBC). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohamed Gholizade
Boushehr University of Medical Sciences
Outcome results
None listed